Immunization; InfectionNCT03379467
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
A study testing SMS Reminder and Interactive Reminder in people with Immunization; Infection and SMS, run by Interactive Research and Development.
Trial summary
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Read more about this study
- Who is it for?
- Ages 6 to 12 weeksHealthy volunteers can take part
- Conditions the study is for
- Immunization; Infection, SMS
- What is being tested?
- SMS Reminder and Interactive Reminder
- Type of treatment
- Vaccines
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 655 participants
- Where
- No sites listed yet
- Study dates
- 23 May 2011to 8 Mar 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 12 weeks
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Child presenting for pentavalent 1- vaccine
- Caregivers who owned a cellphone or had access to one
- Caregivers permanently residing in Korangi Town, Karachi
Who cannot join
- Child presenting for a vaccine other than pentavalent -1
- Caregivers not having access to a cell phone
- Caregivers residing outside of Korangi or planning to move from the catchment area
About this study
Official title: Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential that an immunization intervention be developed that is suitable for its socioeconomic setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very low. Moreover the use of SMS in the country has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification. This study will utilise this prevalence of mobile phones to assess whether simple and interactive sms reminders can serve to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group. 656 participants will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
Read the detailed description
Hypothesis:
The coverage rate of Penta-3, Measles-1 and Measles-2 in infants in Karachi will improve with:
- Short text Messaging Service (SMS) reminders
- Interactive reminders
Aims:
- To determine if SMS reminders increases timely vaccine coverage rate in infants from Karachi.
- To determine if Interactive reminders increases the timely vaccine coverage rate in infants from Karachi.
Background and Rationale:
The World Health Organization's (WHO) goal is to protect all people at risk against vaccine-preventable diseases. The availability of vaccines, however, does not mean that all eligible children are vaccinated. Despite several decades of global efforts in program implementation, vaccine-preventable diseases still contribute 25% of the 10 million deaths/year in under-5 children occurring worldwide. The Expanded Program on Immunization (EPI) does provide wide-access to vaccines in developing countries, but low vaccine uptake and delayed immunizations make infants and children more vulnerable to vaccine preventable diseases. The result of suboptimal immunization rates is the persistent existence of several vaccine preventable diseases. Many different strategies are being tested in these settings to increase immunization coverage, including out-reach services, health education, information dissemination, vaccination requirements for schools, conditional cash transfers and enhancing access to vaccination centers. This study proposes to investigate the use of SMS and interactive text reminders to improve timely immunization coverage. SMS reminders have the potential to increase immunization coverage and could prove to be a simple low cost intervention to improve timely immunization coverage.
SMS reminders Although there is limited data, SMS has been successfully used in various health programs including raising preventive and clinical treatment compliance, increasing HIV testing,4 reducing missed primary care and dental visits etc. Kaewkungwal's study designed a maternal and child care module based on SMS reminders and increased EPI on-time vaccinations to 44% from 35% (p<0.001). Vilella's study showed 47% (95% Confidence Interval (CI): 41-54%) of the participants in SMS reminder intervention arm completed third dose of hepatitis A + B vaccine as compared to 27% (95% CI: 23-32%) in control arm (RR 1.75; 95% CI: 1.41-2.17). SMS reminders have shown a potential simple cost-effective solution to remember the next vaccination date. With the growing use of mobile phones, SMS reminders can be quite useful in health communications. The cost of SMS in Pakistan is very low and use of SMS has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification etc. With such a low cost and varied use of SMS, it has a potential to be a frequent mode of health communications.
Interactive reminders Interactive reminders are a variant of SMS reminders where recipients are asked to respond back to SMS with a specific/non-specific response. Our experience of pilot with interactive reminders to tuberculosis patients to comply with drug adherence has shown positive acceptability. The system can be potentially used for compliance to vaccine schedule. The pilot study will be carried out only in 2 EPI centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group over the 8 weeks follow-up. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
Study site \& Participants:
The study will be conducted in Korangi town, Karachi. Healthy infants 6-12 weeks of age visiting the Indus Hospital EPI center for first dose of pentavalent vaccine will be recruited for the study. Study will require parents/caregivers of infants to own a cell phone or have regular access to one. Parents/caregivers planning to go to a different center for next immunization will be excluded.
Sample size:
A sample of 522 participants would give 90% power (alpha= 0.05, 2-sided) to detect a difference of 15% over the baseline vaccine coverage rate of 70%. The final sample size of 656 infants (164 in each arm) will allow for a potential dropout rate of 20% during the follow-up period.
Randomization Enrolled subjects will be randomized to receive the SMS, interactive SMS or to serve as a control. The randomization sequence was created using SAS, version 9.3 (SAS Institute, Cary, NC), with a 1:1:1 allocation, using random block sizes of 3, 6, and 9.
Vaccines:
The vaccines will be administered as per routine EPI program in Pakistan which include Bacille Calmette-Guérin (BCG) at 0-6 weeks of age, pentavalent (DPT + Hepatitis B (HepB) + Hib) vaccine and oral polio vaccine at 6, 10 and 14 weeks of age, measles vaccine at 9 and 15 months of age.
Interventions:
The two interventions include SMS and interactive reminders. Infants will be randomized to either of the interventions or control groups. All participants will receive the routine EPI immunizations.
Study procedures \& Recruitment:
Children will be recruited at the EPI center when they arrived for the Penta-1 vaccine. Field workers will screen and obtain consent from the child's caregiver. Once the caregiver agrees to be a part of the study the infant will be randomised to one of the study arms and the name and age of the child will be recorded along with the immunization received on the visit. Each infant will be provided with a unique EPI number by the EPI staff and the same identifier (ID) will be used throughout the study to update and maintain the immunization record for all follow up visits. The child will be followed up to the measles 2 vaccine after which their immunization status will be marked as complete.
The parents of infants in SMS and interactive reminder groups will received 3-5 reminders for all scheduled follow-up immunization visits until the measles 2 vaccine. The infants in the control group will carry out routine follow up without any added intervention.
After the completion of follow-up duration a phone interview will be conducted to collect data on experiences of study participants with the SMS and interactive reminders. This will be a brief 3-5 minute interview to confirm if they received the messages and if there were any suggestions to improve the reminder system.
Statistical Analysis An intention to treat analysis will be conducted using STATA'13. Summary statistics and percentages will be calculated to establish coverage and timeliness rates within the three study arms. Fisher's Exact test with an alpha of 0.05 will be conducted to test differences in proportions for coverage and timelines
Additionally to determine factors associated with measles-2 completion at 24 months of age, a bivariate analysis will be conducted.Variables previously examined for association with measles 2 completion at 24 months via a bivariate analysis will then be selected for determining final multivariate model. All the variables will first be used in the model and the coefficients and the vif will be examined. Next, forward selection and step wise selection will be carried out in STATA to determine final model for a logistic regression.
- Conditions
- Immunization; Infection, SMS
- Being tested
- SMS Reminder, Interactive Reminder
- Keywords
- SMS Reminder, Two-way Reminder
- Medical subject headings
- Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SMS ReminderOther
A text message sent as a reminder for immunization on the registered phone number
Interactive ReminderOther
A text message sent as a reminder for immunization on the registered phone number which requires the receiver to respond back
| Study group | Role | What they receive |
|---|---|---|
| SMS Reminder | Experimental | Single SMS at each of the following times:
* 3 days before immunization
* 1 day before immunization
* Day of immunization Receives: Other: SMS Reminder |
| Interactive Reminder | Experimental | Single SMS at each of the following times:
* 3 days before immunization
* 1 day before immunization
* Day of immunization On the day of immunization, study participants are required to respond back through SMS notifying us that child got vaccinated or if not, the reason for delay in immunization. In case of no response, 2 additional reminders will be sent at:
* 1 day after scheduled immunization date
* 1 week after scheduled immunization date Receives: Other: Interactive Reminder |
| Control | No intervention | Subjects in this arm will not receive any intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measles - 2 Completion
The primary outcome for the study is the proportion of infants completing measles 2 vaccine on schedule.
Measured: When the participants reach 2 years of age
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Dec 2017
- Study start23 May 2011
- Primary completion8 Mar 2014
- Study completion8 Mar 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Immunization; InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. The parents of infants in SMS and interactive reminder groups will receive 3-5 reminders for scheduled follow-up immunization visits. The difference in between SMS and interactive reminders is that parents in SMS reminders are not asked to respond back to SMS reminders. The infants in control group will carry out routine follow-ups without any added intervention.
- Masking
- None (open label)
- Enrolment
- 655 participants (actual)
Sponsor and investigators
- Lead sponsor
- Interactive Research and Development
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Subhash Chandir, Interactive Research and Development
- Investigators
- Subhash Chandir, Phd, Principal investigator, Interactive Research and Development (IRD)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03379467
- Sponsor's protocol ID
- IRD_IRB_2011_05_005
- Status last verified
- Dec 2017
- First submitted
- 14 Dec 2017
- Last updated
- 21 Dec 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
PubMed 32813276
Study at a glance
From the registry record, last updated by the sponsor on 21 Dec 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT03379467
- Acronym / sponsor ID
- IRD_IRB_2011_05_005
- Conditions
- Immunization; Infection, SMS
- Keywords
- SMS Reminder, Two-way Reminder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 655 participants (actual)
- Lead sponsor
- Interactive Research and DevelopmentUniversity, hospital or other
- Study start
- 23 May 2011 (actual)
- Primary completion
- 8 Mar 2014 (actual)
- Study completion
- 8 Mar 2014 (actual)
- First posted
- 20 Dec 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential that an immunization intervention be developed that is suitable for its socioeconomic setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very low. Moreover the use of SMS in the country has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification. This study will utilise this prevalence of mobile phones to assess whether simple and interactive sms reminders can serve to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group. 656 participants will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
Detailed description
Hypothesis:
The coverage rate of Penta-3, Measles-1 and Measles-2 in infants in Karachi will improve with:
- Short text Messaging Service (SMS) reminders
- Interactive reminders
Aims:
- To determine if SMS reminders increases timely vaccine coverage rate in infants from Karachi.
- To determine if Interactive reminders increases the timely vaccine coverage rate in infants from Karachi.
Background and Rationale:
The World Health Organization's (WHO) goal is to protect all people at risk against vaccine-preventable diseases. The availability of vaccines, however, does not mean that all eligible children are vaccinated. Despite several decades of global efforts in program implementation, vaccine-preventable diseases still contribute 25% of the 10 million deaths/year in under-5 children occurring worldwide. The Expanded Program on Immunization (EPI) does provide wide-access to vaccines in developing countries, but low vaccine uptake and delayed immunizations make infants and children more vulnerable to vaccine preventable diseases. The result of suboptimal immunization rates is the persistent existence of several vaccine preventable diseases. Many different strategies are being tested in these settings to increase immunization coverage, including out-reach services, health education, information dissemination, vaccination requirements for schools, conditional cash transfers and enhancing access to vaccination centers. This study proposes to investigate the use of SMS and interactive text reminders to improve timely immunization coverage. SMS reminders have the potential to increase immunization coverage and could prove to be a simple low cost intervention to improve timely immunization coverage.
SMS reminders Although there is limited data, SMS has been successfully used in various health programs including raising preventive and clinical treatment compliance, increasing HIV testing,4 reducing missed primary care and dental visits etc. Kaewkungwal's study designed a maternal and child care module based on SMS reminders and increased EPI on-time vaccinations to 44% from 35% (p<0.001). Vilella's study showed 47% (95% Confidence Interval (CI): 41-54%) of the participants in SMS reminder intervention arm completed third dose of hepatitis A + B vaccine as compared to 27% (95% CI: 23-32%) in control arm (RR 1.75; 95% CI: 1.41-2.17). SMS reminders have shown a potential simple cost-effective solution to remember the next vaccination date. With the growing use of mobile phones, SMS reminders can be quite useful in health communications. The cost of SMS in Pakistan is very low and use of SMS has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification etc. With such a low cost and varied use of SMS, it has a potential to be a frequent mode of health communications.
Interactive reminders Interactive reminders are a variant of SMS reminders where recipients are asked to respond back to SMS with a specific/non-specific response. Our experience of pilot with interactive reminders to tuberculosis patients to comply with drug adherence has shown positive acceptability. The system can be potentially used for compliance to vaccine schedule. The pilot study will be carried out only in 2 EPI centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group over the 8 weeks follow-up. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
Study site \& Participants:
The study will be conducted in Korangi town, Karachi. Healthy infants 6-12 weeks of age visiting the Indus Hospital EPI center for first dose of pentavalent vaccine will be recruited for the study. Study will require parents/caregivers of infants to own a cell phone or have regular access to one. Parents/caregivers planning to go to a different center for next immunization will be excluded.
Sample size:
A sample of 522 participants would give 90% power (alpha= 0.05, 2-sided) to detect a difference of 15% over the baseline vaccine coverage rate of 70%. The final sample size of 656 infants (164 in each arm) will allow for a potential dropout rate of 20% during the follow-up period.
Randomization Enrolled subjects will be randomized to receive the SMS, interactive SMS or to serve as a control. The randomization sequence was created using SAS, version 9.3 (SAS Institute, Cary, NC), with a 1:1:1 allocation, using random block sizes of 3, 6, and 9.
Vaccines:
The vaccines will be administered as per routine EPI program in Pakistan which include Bacille Calmette-Guérin (BCG) at 0-6 weeks of age, pentavalent (DPT + Hepatitis B (HepB) + Hib) vaccine and oral polio vaccine at 6, 10 and 14 weeks of age, measles vaccine at 9 and 15 months of age.
Interventions:
The two interventions include SMS and interactive reminders. Infants will be randomized to either of the interventions or control groups. All participants will receive the routine EPI immunizations.
Study procedures \& Recruitment:
Children will be recruited at the EPI center when they arrived for the Penta-1 vaccine. Field workers will screen and obtain consent from the child's caregiver. Once the caregiver agrees to be a part of the study the infant will be randomised to one of the study arms and the name and age of the child will be recorded along with the immunization received on the visit. Each infant will be provided with a unique EPI number by the EPI staff and the same identifier (ID) will be used throughout the study to update and maintain the immunization record for all follow up visits. The child will be followed up to the measles 2 vaccine after which their immunization status will be marked as complete.
The parents of infants in SMS and interactive reminder groups will received 3-5 reminders for all scheduled follow-up immunization visits until the measles 2 vaccine. The infants in the control group will carry out routine follow up without any added intervention.
After the completion of follow-up duration a phone interview will be conducted to collect data on experiences of study participants with the SMS and interactive reminders. This will be a brief 3-5 minute interview to confirm if they received the messages and if there were any suggestions to improve the reminder system.
Statistical Analysis An intention to treat analysis will be conducted using STATA'13. Summary statistics and percentages will be calculated to establish coverage and timeliness rates within the three study arms. Fisher's Exact test with an alpha of 0.05 will be conducted to test differences in proportions for coverage and timelines
Additionally to determine factors associated with measles-2 completion at 24 months of age, a bivariate analysis will be conducted.Variables previously examined for association with measles 2 completion at 24 months via a bivariate analysis will then be selected for determining final multivariate model. All the variables will first be used in the model and the coefficients and the vif will be examined. Next, forward selection and step wise selection will be carried out in STATA to determine final model for a logistic regression.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. The parents of infants in SMS and interactive reminder groups will receive 3-5 reminders for scheduled follow-up immunization visits. The difference in between SMS and interactive reminders is that parents in SMS reminders are not asked to respond back to SMS reminders. The infants in control group will carry out routine follow-ups without any added intervention.
| Arm | Type | Receives |
|---|---|---|
| SMS Reminder | Experimental | Other: SMS ReminderSingle SMS at each of the following times: * 3 days before immunization * 1 day before immunization * Day of immunization |
| Interactive Reminder | Experimental | Other: Interactive ReminderSingle SMS at each of the following times: * 3 days before immunization * 1 day before immunization * Day of immunization On the day of immunization, study participants are required to respond back through SMS notifying us that child got vaccinated or if not, the reason for delay in immunization. In case of no response, 2 additional reminders will be sent at: * 1 day after scheduled immunization date * 1 week after scheduled immunization date |
| Control | No intervention | –Subjects in this arm will not receive any intervention |
Who may qualify
- Ages
- 6 to 12 weeks
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Child presenting for pentavalent 1- vaccine
- Caregivers who owned a cellphone or had access to one
- Caregivers permanently residing in Korangi Town, Karachi
Key exclusion criteria (3 listed)
- Child presenting for a vaccine other than pentavalent -1
- Caregivers not having access to a cell phone
- Caregivers residing outside of Korangi or planning to move from the catchment area
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SMS ReminderA text message sent as a reminder for immunization on the registered phone number | Other | SMS Reminder |
| Interactive ReminderA text message sent as a reminder for immunization on the registered phone number which requires the receiver to respond back | Other | Interactive Reminder |
Primary outcome
Measles - 2 Completion
Time frame: When the participants reach 2 years of age
The primary outcome for the study is the proportion of infants completing measles 2 vaccine on schedule.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Dec 2017.
- Derived from this study: PubMed 32813276Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
- Individual participant dataSharing planned: No
Related trials for Immunization; Infection
RecruitingPhase 1/2
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Herpes Zoster
Active, not recruitingObservational study
Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)
COVID-19 Vaccination
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
Active, not recruiting
HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)
Human Papilloma Virus (HPV) Vaccine
RecruitingPhase 4
BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies
Ebola, Bundibugyo Virus Disease (BVD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Subhash Chandir, Phd principal investigator
Interactive Research and Development (IRD)
Questions about this trial
What is this clinical trial studying?
A study testing SMS Reminder and Interactive Reminder in people with Immunization; Infection and SMS, run by Interactive Research and Development.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measles - 2 Completion (time frame: When the participants reach 2 years of age). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03379467, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2017.